Profile
Full Name
GT Biopharma, Inc.Ticker Symbol
GTBPExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
March 27, 2018Indexes
Not includedWebsite
http://www.gtbiopharma.comEmployees
1Key Details
Price
$2.23(-3.46%)
Market cap
$4.98M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$6.94(-23.05% YoY)
PE ratio
-
Next earnings date
May 15, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
GT Biopharma doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Dec 2, 24 Roth MKM
BuyAug 8, 23 HC Wainwright & Co.
BuyAug 7, 23 EF Hutton
HoldJun 5, 23 HC Wainwright & Co.
BuyMay 17, 23 HC Wainwright & Co.
BuyMay 16, 23 EF Hutton
HoldApr 3, 23 HC Wainwright & Co.
BuyMar 31, 23 EF Hutton
HoldJan 5, 23 EF Hutton
HoldSep 13, 22 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for GT Biopharma?
- Does GT Biopharma pay dividends?
- What sector is GT Biopharma in?
- What industry is GT Biopharma in?
- What country is GT Biopharma based in?
- When did GT Biopharma go public?
- Is GT Biopharma in the S&P 500?
- Is GT Biopharma in the NASDAQ 100?
- Is GT Biopharma in the Dow Jones?
- When was GT Biopharma's last earnings report?
- When does GT Biopharma report earnings?
- Should I buy GT Biopharma stock now?
What is the ticker symbol for GT Biopharma?
The ticker symbol for GT Biopharma is NASDAQ:GTBP
Does GT Biopharma pay dividends?
No, GT Biopharma does not pay dividends
What sector is GT Biopharma in?
GT Biopharma is in the Healthcare sector
What industry is GT Biopharma in?
GT Biopharma is in the Biotechnology industry
What country is GT Biopharma based in?
GT Biopharma is headquartered in United States
When did GT Biopharma go public?
GT Biopharma's initial public offering (IPO) was on March 27, 2018
Is GT Biopharma in the S&P 500?
No, GT Biopharma is not included in the S&P 500 index
Is GT Biopharma in the NASDAQ 100?
No, GT Biopharma is not included in the NASDAQ 100 index
Is GT Biopharma in the Dow Jones?
No, GT Biopharma is not included in the Dow Jones index
When was GT Biopharma's last earnings report?
GT Biopharma's most recent earnings report was on Nov 14, 2024
When does GT Biopharma report earnings?
The next expected earnings date for GT Biopharma is May 15, 2025
Should I buy GT Biopharma stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions